Background: A correlation between plasma CD31+ endothelial microparticles (CD31+EMP) levels and clinical, as well as brain MRI activity, in multiple sclerosis (MS) patients has been previously ...

We have observed a decrease in plasma CD31+EMP following initiation of intramuscular treatment of MS patients with IFN-β1a, 30 µg weekly. This decrease reached significance at week 12 and became ...

CD31, a cell-cell junction protein, plays a crucial role in regulating vascular permeability. Increased vascular permeability can lead to endothelial dysfunction and contribute to the progression ...

Lung nodules are small growths in your lungs, less than 30 millimeters in diameter. Many nodules aren’t cancerous, but the risk becomes higher with increased size. A lung nodule is an irregular ...

June 13, 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been ... Lung Cancer Study Offers ...

It works by presenting the immune system with tumour markers from non-small cell lung cancer, the most common form of the disease, to prime the body to fight cancer cells expressing these markers.

When lung cancer spreads beyond the lungs, it usually first affects nearby lymph nodes. But doctors don’t usually consider lung cancer to be “metastatic” until it has spread to more distant ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

Sep. 12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not ...

Lung cancer starts in your lungs and can spread to other parts of your body. There are more than 20 kinds of lung cancer. Some other conditions can have similar warning signs to lung cancer. It ...